Roman Butler Fullerton & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$2.01M |
| 2 |
CrowdStrike
CRWD
|
+$1.42M |
| 3 |
ServiceNow
NOW
|
+$1.31M |
| 4 |
Microsoft
MSFT
|
+$1.12M |
| 5 |
Cigna
CI
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.53M |
| 2 |
ASML
ASML
|
+$1.29M |
| 3 |
Array Technologies
ARRY
|
+$1.21M |
| 4 |
Axcelis
ACLS
|
+$1.18M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$707K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.68% |
| 2 | Healthcare | 8.92% |
| 3 | Financials | 7.74% |
| 4 | Consumer Discretionary | 7.1% |
| 5 | Consumer Staples | 5.93% |
Similar funds
Roman Butler Fullerton & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Roman Butler Fullerton & Co held 219 positions worth $257M, up 21% from $212M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Roman Butler Fullerton & Co deployed $16.1M of net new capital in Q4 2023, opening 37 new positions and adding to 70 existing holdings. Its largest new stake was Spirit Airlines, Inc.: 139,876 shares worth $874K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $1.53M trimmed.
- Roman Butler Fullerton & Co's largest Q4 2023 buy was Spirit Airlines, Inc.: 139,876 shares worth $874K.
- Roman Butler Fullerton & Co added most to Microsoft in Q4 2023, an estimated $1.12M increase.
- Roman Butler Fullerton & Co's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $1.53M.
- Roman Butler Fullerton & Co fully exited ASML in Q4 2023, selling an estimated $1.29M.
- Roman Butler Fullerton & Co's ten largest holdings make up 31% of its $257M portfolio in Q4 2023.
- Roman Butler Fullerton & Co opened 37 new positions and closed 12 in Q4 2023.
- Roman Butler Fullerton & Co's portfolio value rose 21% quarter-over-quarter to $257M.
Based on Roman Butler Fullerton & Co's 13F filing for Q4 2023, filed 31 Jan 2024.